Live Chat

JnJ gráfico en tiempo real

Fundamentales del instrumento

Weekly Search
Weekly
Daily
Fecha Cerrar Cambio Cambio del % Apertura Alto Bajo

Últimas noticias

US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Adelanto semanal:  El empleo en EE. UU. marcará probablemente el sentimiento de mercado esta semana.

Forex Índices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Adelanto semanal:  Inflación de la Eurozona podría confirmar el recorte del BCE en diciembre

Forex Índices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Adelanto semanal: El rally tecnológico dependerá de los resultados de Nvidia

Forex Índices
Markets.com Support Team 2024 Nov 07, 16:00

Adelanto semanal: «Trump Trade», datos de inflación, resultados de Disney

Forex Índices
US Election 2024, Harris vs Trump
Markets.com Support Team 2024 Oct 31, 16:00

Adelanto semanal: Trump vs Harris - Enfrentamiento electoral en EE. UU.

Forex Índices
Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Markets.com Support Team 2024 Oct 24, 16:00

Adelanto semanal:  Apple encabeza las ganancias de las grandes tecnológicas, presupuesto del Reino Unido y nóminas no agrícolas

Forex Índices
Time for Tesla earnings
Markets.com Support Team 2024 Oct 17, 16:00

Adelanto semanal:  Hora de los resultados de Tesla

Forex Índices
ECB set to cut rates for the third time this year
Markets.com Support Team 2024 Oct 10, 16:00

Adelanto semanal:  El BCE se prepara para recortar las tasas mientras arranca la temporada de ganancias en Wall Street

Forex Índices

Información

Spread

0.92

Spread (%)

0.6136 %

Apalancamiento

1:2

Interés a un día (Compra)

-0.0597 %

Interés a un día (Venta)

-0.0292 %

Divisa

USD

Horarios de los mercados

Markets closed

Jueves

14:31 - 20:59

Lunes

14:31-20:59

Martes

14:31-20:59

Miércoles

14:31-20:59

Viernes

14:31-20:59

Análisis y estadísticas

Apertura

---

Cierre anterior

---

Máximo/mínimo de 52 semanas

--- – ---

Capitalización de mercado

366825013248

Acciones en circulación

2407620096

Fecha de ganancias (próxima)

2001-06-13

Rentabilidad por div.

2024-12-10

Fecha exdividendo

2024-11-26

Tasa de dividendo anual anticipado

4.96

Rendimiento de dividendo anual anticipado

0.032

GPA

6.05

Conoce más sobre este instrumento

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Instrumentos relacionados

Activo
Vender
Comprar
Cambio del %
view_all_instruments
Trustpilot
Live Chat